ask="N/A"
ask_size="N/A"
average_daily_volume="399850"
bid="N/A"
bid_size="N/A"
book_value="14.89"
change="-1.11"
change_from_200_day_moving_average="-2.66"
change_from_50_day_moving_average="-4.68"
change_from_52_week_high="-13.47"
change_From_52_week_low="19.50"
change_in_percent="-2.28%"
close="47.51"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="8.95"
ebitda="267.62M"
eps_estimate_current_year="-2.27"
eps_estimate_next_quarter="-0.74"
eps_estimate_next_year="-3.15"
ex_dividend_date="N/A"
float_shares="24015000"
high="48.45"
high_52_weeks="60.98"
last_trade_date="1/17/2017"
last_trade_price="47.51"
last_trade_size="100"
last_trade_time="4:00pm"
low="46.58"
low_52_weeks="28.01"
market_capitalization="1.29B"
moving_average_200_day="50.17"
moving_average_50_day="52.19"
name="Five Prime Therapeutics
Inc."
notes="N/A"
one_year_target_price="60.17"
open="48.18"
pe_ratio="5.31"
peg_ratio="0.36"
percent_change_from_200_day_moving_average="-5.30%"
percent_change_from_50_day_moving_average="-8.97%"
percent_change_from_52_week_high="-22.09%"
percent_change_from_52_week_low="+69.62%"
previous_close="48.62"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.27"
price_per_sales="3.42"
revenue="385.77M"
shares_outstanding="27138000"
short_ratio="6.09"
stock_exchange="NMS"
symbol="FPRX"
volume="371125"
weeks_range_52="28.01 - 60.98"
